Collagen II Enrichment Through ScAAV6-RNAi-mediated Inhibition of Matrix-metalloproteinases 3 and 13 in Degenerative Nucleus-pulposus Cells Degenerative Disc Disease and Biological Treatment Strategies

Overview

Journal Exp Biol Med (Maywood)

Specialty Biology

Date 2024 Sep 17

PMID 39286594

Authors

Demissew Shenegelegn Mern

Claudius Thome

Affiliations

Soon will be listed here.

Abstract

Intervertebral disc (IVD) degeneration damaging the extracellular matrix (ECM) of IVDs is the main cause of spine-associated disorders. Degenerative disc disease (DDD) is a multifaceted disorder, where environmental factors, inflammatory cytokines and catabolic enzymes act together. DDD starts typically due to imbalance between ECM biosynthesis and degradation within IVDs, especially through unbalanced degradation of aggrecan and collagen II in nucleus pulposus (NP). Current treatment approaches are primarily based on conservative or surgical therapies, which are insufficient for biological regeneration. The disintegrins and metalloproteinases with thrombospondin motifs (ADAMTSs) and matrix metalloproteinases (MMPs) are the key proteolytic enzymes for degradation of aggrecan and collagens. Previously, high expression levels of ADAMTS4, ADAMTS5, MMP3 and MMP13, which are accompanied with low levels of aggrecan and collagen II, were demonstrated in degenerative human NP cells. Moreover, self-complementary adeno-associated virus type 6 (scAAV6) mediated inhibitions of ADAMTS4 and ADAMTS5 by RNA-interference (RNAi) could specifically enhance aggrecan level. Thus, MMPs are apparently the main degrading enzymes of collagen II in NP. Furthermore, scAAV6-mediated inhibitions of MMP3 and MMP13 have not yet been investigated. Therefore, we attempted to enhance the level of collagen II in degenerative NP cells by scAAV6-RNAi-mediated inhibitions of MMP3 and MMP13. MRI was used to determine preoperative grading of IVD degeneration in patients. After isolation and culturing of NP cells, cells were transduced with scAAV6-shRNAs targeting MMP3 or MMP13; and analysed by fluorescence microscopy, FACS, MTT assay, RT-qPCR, ELISA and western blotting. scAAV6-shRNRs have no impact on cell viability and proliferation, despite high transduction efficiencies (98.6%) and transduction units (1383 TU/Cell). Combined knockdown of MMP3 (92.8%) and MMP13 (90.9%) resulted in highest enhancement of collagen II (143.2%), whereby treatment effects were significant over 56 days ( < 0.001). Conclusively, scAAV6-RNAi-mediated inhibitions of MMP3 and MMP13 help to progress less immunogenic and enduring biological treatments in DDD.

References

Freeman B, Davenport J . Total disc replacement in the lumbar spine: a systematic review of the literature. Eur Spine J. 2006; 15 Suppl 3:S439-47. PMC: 2335389. DOI: 10.1007/s00586-006-0186-9. View

Wang M, Shen J, Jin H, Im H, Sandy J, Chen D . Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis. Ann N Y Acad Sci. 2011; 1240:61-9. PMC: 3671949. DOI: 10.1111/j.1749-6632.2011.06258.x. View

Berlemann U, Gries N, Moore R . The relationship between height, shape and histological changes in early degeneration of the lower lumbar discs. Eur Spine J. 1998; 7(3):212-7. PMC: 3611258. DOI: 10.1007/s005860050058. View

Tian Y, Yuan W, Fujita N, Wang J, Wang H, Shapiro I . Inflammatory cytokines associated with degenerative disc disease control aggrecanase-1 (ADAMTS-4) expression in nucleus pulposus cells through MAPK and NF-κB. Am J Pathol. 2013; 182(6):2310-21. PMC: 3668031. DOI: 10.1016/j.ajpath.2013.02.037. View

Kauppila L . Atherosclerosis and disc degeneration/low-back pain--a systematic review. Eur J Vasc Endovasc Surg. 2009; 37(6):661-70. DOI: 10.1016/j.ejvs.2009.02.006. View

Bangdiwala S . Graphical aids for visualizing and interpreting patterns in departures from agreement in ordinal categorical observer agreement data. J Biopharm Stat. 2016; 27(5):773-783. DOI: 10.1080/10543406.2016.1273941. View

Pfirrmann C, Metzdorf A, Zanetti M, Hodler J, Boos N . Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine (Phila Pa 1976). 2001; 26(17):1873-8. DOI: 10.1097/00007632-200109010-00011. View

Roberts S, Evans H, Trivedi J, Menage J . Histology and pathology of the human intervertebral disc. J Bone Joint Surg Am. 2006; 88 Suppl 2:10-4. DOI: 10.2106/JBJS.F.00019. View

Mern D, Tschugg A, Hartmann S, Thome C . Self-complementary adeno-associated virus serotype 6 mediated knockdown of ADAMTS4 induces long-term and effective enhancement of aggrecan in degenerative human nucleus pulposus cells: A new therapeutic approach for intervertebral disc disorders. PLoS One. 2017; 12(2):e0172181. PMC: 5313142. DOI: 10.1371/journal.pone.0172181. View

10.

HART L, Deyo R, Cherkin D . Physician office visits for low back pain. Frequency, clinical evaluation, and treatment patterns from a U.S. national survey. Spine (Phila Pa 1976). 1995; 20(1):11-9. DOI: 10.1097/00007632-199501000-00003. View

11.

Schwarzer A, Aprill C, Derby R, Fortin J, Kine G, Bogduk N . The relative contributions of the disc and zygapophyseal joint in chronic low back pain. Spine (Phila Pa 1976). 1994; 19(7):801-6. DOI: 10.1097/00007632-199404000-00013. View

12.

Boos N, Weissbach S, Rohrbach H, Weiler C, Spratt K, Nerlich A . Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo Award in basic science. Spine (Phila Pa 1976). 2002; 27(23):2631-44. DOI: 10.1097/00007632-200212010-00002. View

13.

Walker B . The prevalence of low back pain: a systematic review of the literature from 1966 to 1998. J Spinal Disord. 2000; 13(3):205-17. DOI: 10.1097/00002517-200006000-00003. View

14.

Tran C, Schoepflin Z, Markova D, Kepler C, Anderson D, Shapiro I . CCN2 suppresses catabolic effects of interleukin-1β through α5β1 and αVβ3 integrins in nucleus pulposus cells: implications in intervertebral disc degeneration. J Biol Chem. 2014; 289(11):7374-87. PMC: 3953253. DOI: 10.1074/jbc.M113.526111. View

15.

Xin W, Heilig J, Paulsson M, Zaucke F . Collagen II regulates chondroycte integrin expression profile and differentiation. Connect Tissue Res. 2015; 56(4):307-14. DOI: 10.3109/03008207.2015.1026965. View

16.

Colombier P, Clouet J, Hamel O, Lescaudron L, Guicheux J . The lumbar intervertebral disc: from embryonic development to degeneration. Joint Bone Spine. 2013; 81(2):125-9. DOI: 10.1016/j.jbspin.2013.07.012. View

17.

Tavakoli J, Elliott D, Costi J . Structure and mechanical function of the inter-lamellar matrix of the annulus fibrosus in the disc. J Orthop Res. 2016; 34(8):1307-15. DOI: 10.1002/jor.23306. View

18.

Klatt A, Zech D, Kuhn G, Paul-Klausch B, Klinger G, Renno J . Discoidin domain receptor 2 mediates the collagen II-dependent release of interleukin-6 in primary human chondrocytes. J Pathol. 2009; 218(2):241-7. DOI: 10.1002/path.2529. View

19.

Roberts S, Urban J, Evans H, Eisenstein S . Transport properties of the human cartilage endplate in relation to its composition and calcification. Spine (Phila Pa 1976). 1996; 21(4):415-20. DOI: 10.1097/00007632-199602150-00003. View

20.

Le Maitre C, Pockert A, Buttle D, Freemont A, Hoyland J . Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem Soc Trans. 2007; 35(Pt 4):652-5. DOI: 10.1042/BST0350652. View